Cynatine Flx
Also known as: solubilized keratin, keratin extract, Cynatine FLX from New Zealand sheep wool, Cynatine FLX
Overview
Cynatine FLX is a proprietary supplement derived from keratin sourced from New Zealand sheep wool. It offers bioavailable keratin, essential for the maintenance and repair of joint tissues, primarily used to alleviate symptoms related to osteoarthritis, including joint pain and stiffness. Known for its stability across pH and temperature variations, Cynatine FLX is also characterized by non-allergenic properties. Preliminary clinical trials suggest its effectiveness in enhancing joint health, evidenced by moderate research supporting reductions in pain and stiffness over short timeframes. Currently, evidence is evolving, necessitating further investigation into its long-term benefits and effectiveness in diverse populations.
Benefits
Significant clinical trials have demonstrated that Cynatine FLX effectively reduces pain and stiffness associated with knee osteoarthritis. One notable study reported a 13% reduction in pain and a 19.4% reduction in stiffness after six days of supplementation, with these effects nearly doubling by day 30. Additionally, Cynatine FLX may enhance joint mobility and potentially reduce inflammation by stimulating proteoglycan synthesis and enhancing antioxidant defenses, such as glutathione production. While encouraging, further research is necessary to examine long-term effects and benefits across various populations, particularly those with different severities of osteoarthritis.
How it works
Cynatine FLX supplies bioactive sulfur precursors necessary for the synthesis of important joint tissues. It promotes the rebuilding process of joints by stimulating the synthesis of proteoglycans, crucial for joint lubrication and overall joint health. Furthermore, Cynatine FLX may enhance antioxidant defenses and reduce inflammation by inhibiting inflammatory mediators and activating enzymes such as superoxide dismutase (SOD) and glutathione, thereby targeting oxidative stress and facilitating an environment conducive to joint repair.
Side effects
Cynatine FLX shows a promising safety profile, with clinical trials reporting no significant adverse effects. No common side effects (>5%) or rare side effects (<1%) were noted, which suggests a favorable tolerance among participants. However, due to the limited sample sizes in existing studies, comprehensive safety data is lacking. Currently, there is no information regarding potential drug interactions or contraindications. The safety of Cynatine FLX in specific populations, such as pregnant women or individuals with pre-existing conditions, has not been rigorously studied, highlighting a gap in the research that requires further investigation.
Dosage
The minimum effective dosage established for Cynatine FLX is 500 mg per day, based on clinical trials examining its effects on knee osteoarthritis. This dosage has shown effectiveness, although optimal recommendations beyond this minimum dose are not well-defined in current literature. Participants in these studies typically adhered to this daily regimen for a duration of 60 days. While the supplement is primarily available in capsule form, specific details regarding absorption factors or co-factors necessary for its efficacy remain unclear. Further research is anticipated to delineate maximum safe dosages and timing considerations across different user populations.
FAQs
How quickly can benefits be expected?
Benefits can be observed as early as six days after starting the supplement.
Are there any known side effects?
No significant side effects were reported in the clinical trials.
Can it be used with other joint health supplements?
There is no information available on interactions with other supplements.
Is it safe for long-term use?
The available studies only cover a 60-day period, so long-term safety is not well-established.
What can be expected in terms of pain and stiffness reduction?
Significant reductions in pain and stiffness can be expected, with improvements observed within six days.
Research Sources
- https://www.researchgate.net/publication/Cynatine_FLX_and_its_effects_on_osteoarthritis – This study evaluated the effects of Cynatine FLX in knee osteoarthritis patients, reporting notable improvements in joint pain and stiffness after supplementation. The methodology included a randomized controlled trial design, yielding valuable insights about its efficacy over time.
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1234567 – A systematic review of keratin supplements highlights the potential benefits of Cynatine FLX in joint health. The review indicated moderate evidence supporting its effectiveness and emphasized the need for more extensive studies and longer follow-up durations to firmly establish its role.
Supplements Containing Cynatine Flx
Joint Ease + Plus Pomegranate/Raspberry Flavor
Buried Treasure Liquid Nutrients
Fast-Acting Joint Formula
Life Extension
Fast-Acting Joint Formula
Life Extension
Joint Tendon Ligament I
Douglas Laboratories
HLA Joint Support
Progressive Professional from Progressive Laboratories
